Systec Launches New and Improved HX-150 Autoclave at MEDICA 2019
|
By LabMedica International staff writers Posted on 18 Nov 2019 |

Illustration
Systec GmbH (Nuremberg, Germany) launched the first product from its re-designed Systec H-Series: the new and improved Systec HX-150 autoclave at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. In addition to the new generation of autoclaves, visitors at MEDICA 2019 got a closer look at several other Systec devices, including not only autoclaves, but also advanced media preparators and the Systec Mediafill dispensing and dosing system. Systec’s partner company Evidencia GmbH also introduced innovative concepts for qualifying and validating equipment and sterilization processes.
MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.
The Systec H-Series floor-standing autoclaves of the performance category HX can be used for all laboratory applications, even for sophisticated sterilization processes and are available in 16 different sizes with 65 to 1580 liters chamber volume. All additional optional accessories can be fitted to obtain validatable processes. In spite of the high loading capacity, these autoclaves are compact and have a comparatively low weight.
The Systec HX-150 autoclave is the world’s first device from the new, improved Systec H-Series – a new generation of autoclaves in a new design, with a completely overhauled interior, and a touchscreen control that has been newly developed from scratch. This combination guarantees more precise work, easier to maintain equipment, and up to 25% faster autoclaving processes. In addition, the new autoclaves come with an Ethernet port as standard and optional Wi-Fi hardware to optimise updating processes, remote maintenance, and remote control of the devices via a computer network. An integrated USB port allows the automated export of documentation data in CSV or PDF format. The volume of the extended internal memory also allows storage of up to 10 years of documentation data. This eliminates the need for separate programs for documentation and archiving that are the otherwise necessary. This integrated documentation function is also interesting from a regulatory point of view, because the new generation of the Systec H- Series automatically fulfils an essential point of the FDA guideline 21 CFR Part 11. Additional features of the series also serve to satisfy regulatory requirements from the pharmaceutical industry, such as automatically distributed, tamper-proof signatures for the PDF and CSV files that are generated, and the tracking of all actions, adjustments, and alerts using AuditTrail.
Related Links:
Systec GmbH
MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.
The Systec H-Series floor-standing autoclaves of the performance category HX can be used for all laboratory applications, even for sophisticated sterilization processes and are available in 16 different sizes with 65 to 1580 liters chamber volume. All additional optional accessories can be fitted to obtain validatable processes. In spite of the high loading capacity, these autoclaves are compact and have a comparatively low weight.
The Systec HX-150 autoclave is the world’s first device from the new, improved Systec H-Series – a new generation of autoclaves in a new design, with a completely overhauled interior, and a touchscreen control that has been newly developed from scratch. This combination guarantees more precise work, easier to maintain equipment, and up to 25% faster autoclaving processes. In addition, the new autoclaves come with an Ethernet port as standard and optional Wi-Fi hardware to optimise updating processes, remote maintenance, and remote control of the devices via a computer network. An integrated USB port allows the automated export of documentation data in CSV or PDF format. The volume of the extended internal memory also allows storage of up to 10 years of documentation data. This eliminates the need for separate programs for documentation and archiving that are the otherwise necessary. This integrated documentation function is also interesting from a regulatory point of view, because the new generation of the Systec H- Series automatically fulfils an essential point of the FDA guideline 21 CFR Part 11. Additional features of the series also serve to satisfy regulatory requirements from the pharmaceutical industry, such as automatically distributed, tamper-proof signatures for the PDF and CSV files that are generated, and the tracking of all actions, adjustments, and alerts using AuditTrail.
Related Links:
Systec GmbH
Latest Medica 2019 News
- Mast Group Introduces New MAST CARBA PAcE for Rapid Carbapenemase Detection
- DRG Instruments Demonstrates DRG:HYBRID-XL Fully Automated Lab Analyzer
- Diatron Introduces New Aquila 5Dretic 5-Part Differential Hematology Analyzer
- Alifax S.r.l. Highlights First Automated System for Bacterial Culture and Susceptibility Testing
- Erba Mannheim Showcases New Launches at MEDICA 2019
- EUROIMMUN Showcases Immunoassay Testing Products at MEDICA 2019
- Diconex S.A. Exhibits InCCA Intelligent Clinical Chemistry Analyzer at MEDICA 2019
- Chembio Diagnostics Showcases New DPP Line of Rapid Tests at MEDICA 2019
- DYNEX Demonstrates DYNABLOT Automatic Analyzer for Immunoblot and Westernblot Methods
- TaiDoc Showcases Multi-Parameter Monitoring Systems and Advanced Devices
- IDS Exhibits Next Generation Automated Immunoanalyzer IDS-i10 at MEDICA 2019
- JEOL Ltd. Introduces BioMajesty Series of Clinical Chemistry Analyzers at MEDICA 2019
- EKF Diagnostics Showcases Full Product Range at MEDICA 2019
Channels
Clinical Chemistry
view channel
Point-of-Care Blood Biomarker Test Detects Brain Injury Missed by CT
Traumatic brain injury remains difficult to assess in emergency settings because some patients continue to have symptoms despite normal computed tomography findings. Approximately 2.8 million people in the U.... Read more
Daily Blood Testing May Help Guide Earlier Antibiotic Stopping in Sepsis
Sepsis is a life-threatening condition caused by the body’s overwhelming response to infection and accounts for thousands of deaths each year. In intensive care, concern about stopping treatment too early... Read moreMolecular Diagnostics
view channel
Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use
Vaginitis affects most women at least once in their lifetime and can cause painful, disruptive symptoms. Common causes include bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, reflecting... Read more
AI Tool Predicts Immunotherapy Response Using Tumor Senescence Signals
Patients receiving the same cancer immunotherapy can have markedly different outcomes, with some showing little or no response. Identifying these patients earlier could reduce the costs of ineffective... Read moreHematology
view channel
New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read more
Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Trauma
Severe blood loss and inadequate tissue oxygenation are leading causes of preventable death after traumatic injury. Blood products are essential in trauma care, but cold-chain storage, short shelf life,... Read moreImmunology
view channel
Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis
Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more
Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more
Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk
A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more
Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Childhood
Food allergy is a major childhood health concern, and distinguishing persistent risk from transient sensitization can guide clinical decisions. Specific IgE antibodies may be detectable even when a child... Read moreMicrobiology
view channel
Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response
The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read more
Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis
Sepsis and severe infections are difficult to treat because patients with similar clinical presentations may have very different underlying immune responses. Corticosteroids are commonly used in severe... Read morePathology
view channel
Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer
In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more
AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer
High-grade serous tubo-ovarian carcinoma is an aggressive cancer arising in the ovaries or fallopian tubes. Some tumors exhibit homologous recombination deficiency (HRD), a feature reflecting impaired DNA repair.... Read moreTechnology
view channel
New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows
Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read moreLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read moreIndustry
view channel
Qiagen Agrees to Go Private Through EQT-Led Acquisition
QIAGEN N.V. (Venlo, the Netherlands) and EQT Private Equity (Stockholm, Sweden) have agreed to an all-cash public takeover offer for all outstanding QIAGEN shares at EUR 46.50 per share.... Read more
Hologic and Inpeco Partner to Advance Molecular Laboratory Automation in Europe
Hologic, Inc. (Marlborough, MA, USA) and Inpeco S.A. (Novazzano, Switzerland) have signed a co-marketing partnership in Europe for Inpeco’s recently launched FlexLab X automation solution and Hologic’s... Read more








